Abstract
No AccessJournal of UrologyUrological Survey1 Jul 2019Re: Polypharmacy, Chronic Kidney Disease, and Benign Prostatic Hyperplasia in Patients with Chronic Obstructive Pulmonary Disease Newly Treated with Long-Acting Anticholinergics Steven A. KaplanMD Steven A. KaplanSteven A. Kaplan More articles by this author View All Author Informationhttps://doi.org/10.1097/01.JU.0000557737.50592.3dAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Re: Polypharmacy, Chronic Kidney Disease, and Benign Prostatic Hyperplasia in Patients with Chronic Obstructive Pulmonary Disease Newly Treated with Long-Acting Anticholinergics." The Journal of Urology, 202(1), pp. 6–7 Suggested Reading : Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol 2011; 185: 1793. Link, Google Scholar © 2019 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 202Issue 1July 2019Page: 6-7 Advertisement Copyright & Permissions© 2019 by American Urological Association Education and Research, Inc.MetricsAuthor Information Steven A. Kaplan More articles by this author Expand All Advertisement Loading ...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
